These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20610536)

  • 21. How do thyroid hormone receptors bind to structurally diverse response elements?
    Desvergne B
    Mol Cell Endocrinol; 1994 Apr; 100(1-2):125-31. PubMed ID: 8056146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similar ligand-induced conformational changes of thyroid hormone receptors regulate homo- and heterodimeric functions.
    Bendik I; Pfahl M
    J Biol Chem; 1995 Feb; 270(7):3107-14. PubMed ID: 7852392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene.
    Toyoda N; Zavacki AM; Maia AL; Harney JW; Larsen PR
    Mol Cell Biol; 1995 Sep; 15(9):5100-12. PubMed ID: 7651427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements.
    Zechel C; Shen XQ; Chambon P; Gronemeyer H
    EMBO J; 1994 Mar; 13(6):1414-24. PubMed ID: 8137825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definition of the surface in the thyroid hormone receptor ligand binding domain for association as homodimers and heterodimers with retinoid X receptor.
    Ribeiro RC; Feng W; Wagner RL; Costa CH; Pereira AC; Apriletti JW; Fletterick RJ; Baxter JD
    J Biol Chem; 2001 May; 276(18):14987-95. PubMed ID: 11145963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA binding and dimerization determinants for thyroid hormone receptor alpha and its interaction with a nuclear protein.
    Zhang XK; Tran PB; Pfahl M
    Mol Endocrinol; 1991 Dec; 5(12):1909-20. PubMed ID: 1791838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of v-erbA homodimers and heterodimers in mediating dominant negative activity by v-erbA.
    Yen PM; Ikeda M; Brubaker JH; Forgione M; Sugawara A; Chin WW
    J Biol Chem; 1994 Jan; 269(2):903-9. PubMed ID: 7904604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid hormone response elements differentially modulate the interactions of thyroid hormone receptors with two receptor binding domains in the steroid receptor coactivator-1.
    Takeshita A; Yen PM; Ikeda M; Cardona GR; Liu Y; Koibuchi N; Norwitz ER; Chin WW
    J Biol Chem; 1998 Aug; 273(34):21554-62. PubMed ID: 9705285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Region-specific anti-thyroid hormone receptor (TR) antibodies detect changes in TR structure due to ligand-binding and dimerization.
    Yen PM; Sugawara A; Forgione M; Spanjaard RA; Macchia E; Cheng SY; Chin WW
    Mol Cell Endocrinol; 1993 Nov; 97(1-2):93-9. PubMed ID: 7511545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential DNA binding by monomeric, homodimeric, and potentially heteromeric forms of the thyroid hormone receptor.
    Lazar MA; Berrodin TJ; Harding HP
    Mol Cell Biol; 1991 Oct; 11(10):5005-15. PubMed ID: 1922030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors.
    Perlmann T; Umesono K; Rangarajan PN; Forman BM; Evans RM
    Mol Endocrinol; 1996 Aug; 10(8):958-66. PubMed ID: 8843412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
    Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
    J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements.
    Cohen RN; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 1998 Oct; 12(10):1567-81. PubMed ID: 9773980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rearrangements in thyroid hormone receptor charge clusters that stabilize bound 3,5',5-triiodo-L-thyronine and inhibit homodimer formation.
    Togashi M; Nguyen P; Fletterick R; Baxter JD; Webb P
    J Biol Chem; 2005 Jul; 280(27):25665-73. PubMed ID: 15886199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homodimer and heterodimer DNA binding and transcriptional responsiveness to triiodothyronine (T3) and 9-cis-retinoic acid are determined by the number and order of high affinity half-sites in a T3 response element.
    Force WR; Tillman JB; Sprung CN; Spindler SR
    J Biol Chem; 1994 Mar; 269(12):8863-71. PubMed ID: 8132622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triiodothyronine (T3) differentially affects T3-receptor/retinoic acid receptor and T3-receptor/retinoid X receptor heterodimer binding to DNA.
    Yen PM; Sugawara A; Chin WW
    J Biol Chem; 1992 Nov; 267(32):23248-52. PubMed ID: 1331079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural features of thyroid hormone response elements that increase susceptibility to inhibition by an RTH mutant thyroid hormone receptor.
    Zavacki AM; Harney JW; Brent GA; Larsen PR
    Endocrinology; 1996 Jul; 137(7):2833-41. PubMed ID: 8770904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The unique C-termini of the thyroid hormone receptor variant, c-erbA alpha 2, and thyroid hormone receptor alpha 1 mediate different DNA-binding and heterodimerization properties.
    Katz D; Berrodin TJ; Lazar MA
    Mol Endocrinol; 1992 May; 6(5):805-14. PubMed ID: 1318505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel roles of retinoid X receptor (RXR) and RXR ligand in dynamically modulating the activity of the thyroid hormone receptor/RXR heterodimer.
    Li D; Yamada T; Wang F; Vulin AI; Samuels HH
    J Biol Chem; 2004 Feb; 279(9):7427-37. PubMed ID: 14668324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference in dominant negative activities between mutant thyroid hormone receptors alpha1 and beta1 with an identical truncation in the extreme carboxyl-terminal tau4 domain.
    Nishiyama K; Andoh S; Kitahara A; Natsume H; Mikami T; Genma R; Nakamura H
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):95-104. PubMed ID: 9685218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.